Skip to content
Riskpilot
← Back to search
Sign in
Get full access
INSULIFE AS
AS
Active
Org 925128554
Gaustadalléen 21, 0349
Oslo
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2020 · 6 years old
5 employees
www.insulife.com
Monitor
Share
Norway
/
Companies
/
Manufacture of pharmaceutical preparations
/
INSULIFE AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
-5M
-9M
-14M
-19M
-1M
2020
-5M
-400%
2021
-9M
-80%
2022
-15M
-67%
2023
-13M
+13%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
56
Staff expenses
−351
−3 561
−5 747
−5 876
−6 877
EBITDA
−632
−4 599
−9 143
−14 674
−13 016
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−632
−4 599
−9 143
−14 674
−13 016
Net financials
46
−14
475
164
119
Profit before tax
−586
−4 613
−8 668
−14 511
−12 897
Tax
−139
139
−0
−0
−0
Net profit
−447
−4 752
−8 668
−14 511
−12 897
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
3 595
11 341
31 438
29 125
28 665
Equity
1 533
9 299
29 088
25 053
22 071
Long-term debt
0
0
595
1 490
978
Short-term debt
2 062
2 042
1 755
2 582
5 617
Total debt
2 062
2 042
2 350
4 072
6 594
Financial ratios
5-year trend
EBITDA margin
-23243.4%
This company
15.8%
Market median
-147210% vs market
2020
2024
Equity ratio
77.0%
This company
38.2%
Market median
+102% vs market
2020
2024
Return on equity
-58.4%
This company
18.4%
Market median
-417% vs market
2020
2024
Net profit margin
-23030.0%
This company
8.1%
Market median
-284421% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-03-31 – 2020-12-31
View
PDF
More on INSULIFE AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
